Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
Merçé Boada, Oscar L. López, Javier Olazarán, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 10, pp. 1412-1425
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 320
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2023) Vol. 38, Iss. 2, pp. 77-278
Closed Access | Times Cited: 275
Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
M. Mahafuzur Rahman, Christofer Lendel
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 147
Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function
Chia‐Chen Liu, Jing Zhao, Yuan Fu, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 8, pp. 1020-1033
Open Access | Times Cited: 99
Blood-to-brain communication in aging and rejuvenation
Gregor Bieri, Adam B. Schroer, Saul Villeda
Nature Neuroscience (2023)
Open Access | Times Cited: 86
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
Yuan Cheng, Chen-Yang He, Ding‐Yuan Tian, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 6, pp. 717-731
Closed Access | Times Cited: 52
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
Amanda Cano, Patric Turowski, Miren Ettcheto, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 86
The role of the immune system in Alzheimer’s disease
Kaimin Wu, Ya-Ru Zhang, Yu‐Yuan Huang, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101409-101409
Closed Access | Times Cited: 78
Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease
Ding‐Yuan Tian, Yuan Cheng, Zhen‐Qian Zhuang, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 6074-6082
Closed Access | Times Cited: 73
Alzheimer’s disease clinical trial update 2019–2021
Joseph Pleen, Ryan Townley
Journal of Neurology (2021) Vol. 269, Iss. 2, pp. 1038-1051
Closed Access | Times Cited: 60
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
David A. Loeffler
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 873-899
Open Access | Times Cited: 34
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Xi-Yuen Kuan, Nurul Syahira Ahmad Fauzi, Khuen Yen Ng, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4169-4183
Open Access | Times Cited: 24
Lessons from antiamyloid-β immunotherapies in Alzheimer's disease
Germán Plascencia‐Villa, George Perry
Handbook of clinical neurology (2023), pp. 267-291
Closed Access | Times Cited: 23
A multimodal deep learning approach for the prediction of cognitive decline and its effectiveness in clinical trials for Alzheimer’s disease
Caihua Wang, Hisateru Tachimori, Hiroyuki Yamaguchi, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Red blood cell distribution width to albumin ratio (RAR) is associated with low cognitive performance in American older adults: NHANES 2011–2014
Binyang Yu, Min Li, Zongliang Yu, et al.
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The multifaceted role of platelets in mediating brain function
Thierry Burnouf, Tara L. Walker
Blood (2022) Vol. 140, Iss. 8, pp. 815-827
Open Access | Times Cited: 34
Human serum albumin in neurodegeneration
Sajjad Shojai, S. Rohani, Ali Akbar Moosavi‐Movahedi, et al.
Reviews in the Neurosciences (2022) Vol. 33, Iss. 7, pp. 803-817
Closed Access | Times Cited: 32
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 32
Inhibition of toxic metal-alpha synuclein interactions by human serum albumin
Karla Martinez Pomier, Rashik Ahmed, Jinfeng Huang, et al.
Chemical Science (2024) Vol. 15, Iss. 10, pp. 3502-3515
Open Access | Times Cited: 7
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
Hannah Preßler, Marie-Luise Machule, Friederike Ufer, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
An investigation into the potential association between nutrition and Alzheimer’s disease
Mingyue He, Teng-hong Lian, Zhan Liu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6683-6683
Open Access | Times Cited: 6
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand
Anneke Brand, Vincenzo De Angelis, Tomislav Vuk, et al.
Transfusion Clinique et Biologique (2020) Vol. 28, Iss. 1, pp. 96-122
Closed Access | Times Cited: 40
Reminiscence therapy using virtual reality technology affects cognitive function and subjective well-being in older adults with dementia
Maho Tominari, Ryuji Uozumi, Carl Becker, et al.
Cogent Psychology (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer’s disease by whole blood exchange
Akihiko Urayama, Inés Moreno‐González, Diego Morales‐Scheihing, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4285-4296
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top